Page last updated: 2024-08-21

pyrazines and Huntington Disease

pyrazines has been researched along with Huntington Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Danduga, RCSR; Dondapati, SR; Grace, L; Kanakaraju, VK; Kola, PK; Tadigiri, RVB1
Ashdown, H; Boucher, M; Bureau, Y; Colucci, J; Degen, S; Flückiger, JP; Giroux, A; Han, Y; Ng, GY; Nicholson, DW; O'Donnell, R; Pikounis, B; Rigby, M; Robertson, GS; Roy, S; Tam, J; Tang, K; Toulmond, S; Xanthoudakis, S; Zamboni, R; Zhu, Y1
Auguet, M; Chabrier, PE; Demerlé-Pallardy, C1

Reviews

1 review(s) available for pyrazines and Huntington Disease

ArticleYear
Nitric oxide synthases: targets for therapeutic strategies in neurological diseases.
    Cellular and molecular life sciences : CMLS, 1999, Volume: 55, Issue:8-9

    Topics: Alzheimer Disease; Amidines; Amyotrophic Lateral Sclerosis; Animals; Benzylamines; Brain Injuries; Brain Ischemia; Enzyme Induction; Humans; Huntington Disease; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Nerve Degeneration; Nerve Tissue Proteins; Nervous System Diseases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Organ Specificity; Polymethacrylic Acids; Pyrazines; Thiophenes

1999

Other Studies

2 other study(ies) available for pyrazines and Huntington Disease

ArticleYear
Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 105

    Topics: Animals; Behavior, Animal; Catalase; Corpus Striatum; Glutathione; Hippocampus; Huntington Disease; Lipid Peroxidation; Male; Maze Learning; Mitochondria; Motor Activity; Neuroprotection; Neuroprotective Agents; Neurotoxicity Syndromes; Nitro Compounds; Oxidative Stress; Propionates; Pyrazines; Rats; Rats, Wistar; Superoxide Dismutase

2018
Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease.
    British journal of pharmacology, 2004, Volume: 141, Issue:4

    Topics: Animals; Autoradiography; Caspase 3; Caspase Inhibitors; Cell Count; Cell Death; Diffusion; Dizocilpine Maleate; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Excitatory Amino Acid Antagonists; Half-Life; Huntington Disease; Male; Malonates; Neostriatum; Neurons; Neuroprotective Agents; Oxadiazoles; Pyrazines; Rats; Rats, Sprague-Dawley

2004